|
1
|
Perez-Duran F, Calderon-Rico F, Franco-Correa LE, Zamora-Aviles AG, Ortega-Flores R, Durand-Herrera D, Bravo-Patiño A, Cortes-Vieyra R, Hernandez-Morales I, Nuñez-Anita RE. Synthetic Peptides Elicit Humoral Response against Porcine Reproductive and Respiratory Syndrome Virus in Swine. Vaccines (Basel) 2024; 12:652. [PMID: 38932381 PMCID: PMC11209519 DOI: 10.3390/vaccines12060652] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2024] [Revised: 06/06/2024] [Accepted: 06/07/2024] [Indexed: 06/28/2024] Open
Abstract
The aim of this study was to analyze the immunogenic response elicited in swine by two synthetic peptides derived from GP5 to understand the role of lineal B epitopes in the humoral and B-cell-mediated response against the porcine reproductive and respiratory syndrome virus (PRRSV). For inoculation, twenty-one-day-old pigs were allocated into six groups: control, vehicle, vaccinated (Ingelvac-PRRSV, MLV®), non-vaccinated and naturally infected, GP5-B and GP5-B3. At 2 days post-immunization (dpi), the GP5-B3 peptide increased the serum concentrations of cytokines associated with activate adaptive cellular immunity, IL-1β (1.15 ± 1.15 to 10.17 ± 0.94 pg/mL) and IL-12 (323.8 ± 23.3 to 778.5 ± 58.11 pg/mL), compared to the control group. The concentration of IgGs anti-GP5-B increased in both cases at 21 and 42 dpi compared to that at 0 days (128.3 ± 8.34 ng/mL to 231.9 ± 17.82 and 331 ± 14.86 ng/mL), while IgGs anti-GP5-B3 increased at 21 dpi (105.1 ± 19.06 to 178 ± 15.09 ng/mL) and remained at the same level until 42 dpi. Also, antibody-forming/Plasma B cells (CD2+/CD21-) increased in both cases (9.85 ± 0.7% to 13.67 ± 0.44 for GP5-B and 15.72 ± 1.27% for GP5-B3). Furthermore, primed B cells (CD2-/CD21+) from immunized pigs showed an increase in both cases (9.62 ± 1.5% to 24.51 ± 1.3 for GP5-B and 34 ± 2.39% for GP5-B3) at 42 dpi. Conversely the naïve B cells from immunized pigs decreased compared with the control group (8.84 ± 0.63% to 6.25 ± 0.66 for GP5-B and 5.78 ± 0.48% for GP5-B3). Importantly, both GP5-B and GP5-B3 peptides exhibited immunoreactivity against serum antibodies from the vaccinated group, as well as the non-vaccinated and naturally infected group. In conclusion, GP5-B and GP5-B3 peptides elicited immunogenicity mediated by antigen-specific IgGs and B cell activation.
Collapse
Affiliation(s)
- Francisco Perez-Duran
- Facultad de Medicina Veterinaria y Zootecnia, Universidad Michoacana de San Nicolas de Hidalgo, Km. 9.5 S/N Carretera Morelia-Zinapecuaro, La Palma, Tarimbaro CP 58893, Mexico; (F.P.-D.); (F.C.-R.); (L.E.F.-C.); (A.G.Z.-A.); (R.O.-F.); (D.D.-H.); (A.B.-P.); (R.C.-V.)
| | - Fernando Calderon-Rico
- Facultad de Medicina Veterinaria y Zootecnia, Universidad Michoacana de San Nicolas de Hidalgo, Km. 9.5 S/N Carretera Morelia-Zinapecuaro, La Palma, Tarimbaro CP 58893, Mexico; (F.P.-D.); (F.C.-R.); (L.E.F.-C.); (A.G.Z.-A.); (R.O.-F.); (D.D.-H.); (A.B.-P.); (R.C.-V.)
| | - Luis Enrique Franco-Correa
- Facultad de Medicina Veterinaria y Zootecnia, Universidad Michoacana de San Nicolas de Hidalgo, Km. 9.5 S/N Carretera Morelia-Zinapecuaro, La Palma, Tarimbaro CP 58893, Mexico; (F.P.-D.); (F.C.-R.); (L.E.F.-C.); (A.G.Z.-A.); (R.O.-F.); (D.D.-H.); (A.B.-P.); (R.C.-V.)
| | - Alicia Gabriela Zamora-Aviles
- Facultad de Medicina Veterinaria y Zootecnia, Universidad Michoacana de San Nicolas de Hidalgo, Km. 9.5 S/N Carretera Morelia-Zinapecuaro, La Palma, Tarimbaro CP 58893, Mexico; (F.P.-D.); (F.C.-R.); (L.E.F.-C.); (A.G.Z.-A.); (R.O.-F.); (D.D.-H.); (A.B.-P.); (R.C.-V.)
| | - Roberto Ortega-Flores
- Facultad de Medicina Veterinaria y Zootecnia, Universidad Michoacana de San Nicolas de Hidalgo, Km. 9.5 S/N Carretera Morelia-Zinapecuaro, La Palma, Tarimbaro CP 58893, Mexico; (F.P.-D.); (F.C.-R.); (L.E.F.-C.); (A.G.Z.-A.); (R.O.-F.); (D.D.-H.); (A.B.-P.); (R.C.-V.)
| | - Daniel Durand-Herrera
- Facultad de Medicina Veterinaria y Zootecnia, Universidad Michoacana de San Nicolas de Hidalgo, Km. 9.5 S/N Carretera Morelia-Zinapecuaro, La Palma, Tarimbaro CP 58893, Mexico; (F.P.-D.); (F.C.-R.); (L.E.F.-C.); (A.G.Z.-A.); (R.O.-F.); (D.D.-H.); (A.B.-P.); (R.C.-V.)
| | - Alejandro Bravo-Patiño
- Facultad de Medicina Veterinaria y Zootecnia, Universidad Michoacana de San Nicolas de Hidalgo, Km. 9.5 S/N Carretera Morelia-Zinapecuaro, La Palma, Tarimbaro CP 58893, Mexico; (F.P.-D.); (F.C.-R.); (L.E.F.-C.); (A.G.Z.-A.); (R.O.-F.); (D.D.-H.); (A.B.-P.); (R.C.-V.)
| | - Ricarda Cortes-Vieyra
- Facultad de Medicina Veterinaria y Zootecnia, Universidad Michoacana de San Nicolas de Hidalgo, Km. 9.5 S/N Carretera Morelia-Zinapecuaro, La Palma, Tarimbaro CP 58893, Mexico; (F.P.-D.); (F.C.-R.); (L.E.F.-C.); (A.G.Z.-A.); (R.O.-F.); (D.D.-H.); (A.B.-P.); (R.C.-V.)
| | - Ilane Hernandez-Morales
- Laboratorio de Investigacion Interdisciplinaria, Escuela Nacional de Estudios Superiores Unidad Leon, Universidad Nacional Autonoma de Mexico, Blv. UNAM No. 2011, Leon CP 37684, Mexico;
| | - Rosa Elvira Nuñez-Anita
- Facultad de Medicina Veterinaria y Zootecnia, Universidad Michoacana de San Nicolas de Hidalgo, Km. 9.5 S/N Carretera Morelia-Zinapecuaro, La Palma, Tarimbaro CP 58893, Mexico; (F.P.-D.); (F.C.-R.); (L.E.F.-C.); (A.G.Z.-A.); (R.O.-F.); (D.D.-H.); (A.B.-P.); (R.C.-V.)
| |
Collapse
|
|
2
|
Petro-Turnquist E, Pekarek MJ, Weaver EA. Swine influenza A virus: challenges and novel vaccine strategies. Front Cell Infect Microbiol 2024; 14:1336013. [PMID: 38633745 PMCID: PMC11021629 DOI: 10.3389/fcimb.2024.1336013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2023] [Accepted: 03/21/2024] [Indexed: 04/19/2024] Open
Abstract
Swine Influenza A Virus (IAV-S) imposes a significant impact on the pork industry and has been deemed a significant threat to global public health due to its zoonotic potential. The most effective method of preventing IAV-S is vaccination. While there are tremendous efforts to control and prevent IAV-S in vulnerable swine populations, there are considerable challenges in developing a broadly protective vaccine against IAV-S. These challenges include the consistent diversification of IAV-S, increasing the strength and breadth of adaptive immune responses elicited by vaccination, interfering maternal antibody responses, and the induction of vaccine-associated enhanced respiratory disease after vaccination. Current vaccination strategies are often not updated frequently enough to address the continuously evolving nature of IAV-S, fail to induce broadly cross-reactive responses, are susceptible to interference, may enhance respiratory disease, and can be expensive to produce. Here, we review the challenges and current status of universal IAV-S vaccine research. We also detail the current standard of licensed vaccines and their limitations in the field. Finally, we review recently described novel vaccines and vaccine platforms that may improve upon current methods of IAV-S control.
Collapse
Affiliation(s)
- Erika Petro-Turnquist
- Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE, United States
- School of Biological Sciences, University of Nebraska-Lincoln, Lincoln, NE, United States
| | - Matthew J. Pekarek
- Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE, United States
- School of Biological Sciences, University of Nebraska-Lincoln, Lincoln, NE, United States
| | - Eric A. Weaver
- Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE, United States
- School of Biological Sciences, University of Nebraska-Lincoln, Lincoln, NE, United States
| |
Collapse
|
|
3
|
Liu D, Chen Y. Epitope screening and vaccine molecule design of PRRSV GP3 and GP5 protein based on immunoinformatics. J Cell Mol Med 2024; 28:e18103. [PMID: 38217314 PMCID: PMC10844699 DOI: 10.1111/jcmm.18103] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2023] [Revised: 11/22/2023] [Accepted: 11/30/2023] [Indexed: 01/15/2024] Open
Abstract
Porcine reproductive and respiratory syndrome (PRRS) is a respiratory disease in pigs that causes severe economic losses. Currently, live PRRSV vaccines are commonly used but fail to prevent PRRS outbreaks and reinfection. Inactivated PRRSV vaccines have poor immunogenicity, making PRRSV a significant threat to swine health globally. Therefore, there is an urgent need to develop an effective PRRSV vaccine. This study used immunoinformatics to predict, screen, design and construct a candidate vaccine that fused B-cell epitopes, CTL- and HTL-dominant protective epitopes of PRRSV strain's GP3 and GP5 proteins. The study identified 12 B-cell epitopes, 6 CTL epitopes and 5 HTL epitopes of GP3 and GP5 proteins. The candidate vaccine was constructed with 50S ribosomal protein L7/L1 molecular adjuvant, which has antigenicity, solubility, stability, non-allergenicity and a high affinity for its target receptor, TLR-3. The C-ImmSim immunostimulation results showed significant increases in cellular and humoral responses (B cells and T cells) and production of TGF-β, IL-2, IL-10, IFN-γ and IL-12. The constructed vaccine was stable and immunogenic, and it can effectively induce strong T-cell and B-cell immune responses against PRRSV. Therefore, it is a promising candidate vaccine for controlling and preventing PRRSV outbreaks.
Collapse
Affiliation(s)
- Dongyu Liu
- Heilongjiang Bayi Agricultural UniversityDaqingChina
| | - Yaping Chen
- Heilongjiang Bayi Agricultural UniversityDaqingChina
| |
Collapse
|
|
4
|
Zhang H, Luo Q, He Y, Zheng Y, Sha H, Li G, Kong W, Liao J, Zhao M. Research Progress on the Development of Porcine Reproductive and Respiratory Syndrome Vaccines. Vet Sci 2023; 10:491. [PMID: 37624278 PMCID: PMC10459618 DOI: 10.3390/vetsci10080491] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2023] [Revised: 07/26/2023] [Accepted: 07/27/2023] [Indexed: 08/26/2023] Open
Abstract
Porcine reproductive and respiratory syndrome (PRRS) is a highly contagious disease in the pig industry, but its pathogenesis is not yet fully understood. The disease is caused by the PRRS virus (PRRSV), which primarily infects porcine alveolar macrophages and disrupts the immune system. Unfortunately, there is no specific drug to cure PRRS, so vaccination is crucial for controlling the disease. There are various types of single and combined vaccines available, including live, inactivated, subunit, DNA, and vector vaccines. Among them, live vaccines provide better protection, but cross-protection is weak. Inactivated vaccines are safe but have poor immune efficacy. Subunit vaccines can be used in the third trimester of pregnancy, and DNA vaccines can enhance the protective effect of live vaccines. However, vector vaccines only confer partial protection and have not been widely used in practice. A PRRS vaccine that meets new-generation international standards is still needed. This manuscript provides a comprehensive review of the advantages, disadvantages, and applicability of live-attenuated, inactivated, subunit, live vector, DNA, gene-deletion, synthetic peptide, virus-like particle, and other types of vaccines for the prevention and control of PRRS. The aim is to provide a theoretical basis for vaccine research and development.
Collapse
Affiliation(s)
- Hang Zhang
- School of Life Science and Engineering, Foshan University, Foshan 528000, China; (H.Z.); (Q.L.); (Y.H.); (Y.Z.); (H.S.); (G.L.)
| | - Qin Luo
- School of Life Science and Engineering, Foshan University, Foshan 528000, China; (H.Z.); (Q.L.); (Y.H.); (Y.Z.); (H.S.); (G.L.)
| | - Yingxin He
- School of Life Science and Engineering, Foshan University, Foshan 528000, China; (H.Z.); (Q.L.); (Y.H.); (Y.Z.); (H.S.); (G.L.)
| | - Yajie Zheng
- School of Life Science and Engineering, Foshan University, Foshan 528000, China; (H.Z.); (Q.L.); (Y.H.); (Y.Z.); (H.S.); (G.L.)
| | - Huiyang Sha
- School of Life Science and Engineering, Foshan University, Foshan 528000, China; (H.Z.); (Q.L.); (Y.H.); (Y.Z.); (H.S.); (G.L.)
| | - Gan Li
- School of Life Science and Engineering, Foshan University, Foshan 528000, China; (H.Z.); (Q.L.); (Y.H.); (Y.Z.); (H.S.); (G.L.)
| | - Weili Kong
- Gladstone Institutes of Virology and Immunology, University of California, San Francisco, CA 94158, USA;
| | - Jiedan Liao
- School of Life Science and Engineering, Foshan University, Foshan 528000, China; (H.Z.); (Q.L.); (Y.H.); (Y.Z.); (H.S.); (G.L.)
| | - Mengmeng Zhao
- School of Life Science and Engineering, Foshan University, Foshan 528000, China; (H.Z.); (Q.L.); (Y.H.); (Y.Z.); (H.S.); (G.L.)
| |
Collapse
|